Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 23,000 shares, a drop of 64.2% from the September 15th total of 64,300 shares. Based on an average daily volume of 1,093,500 shares, the short-interest ratio is currently 0.0 days.

Q BioMed Stock Performance

Q BioMed stock remained flat at $0.01 during midday trading on Thursday. 724,212 shares of the company were exchanged, compared to its average volume of 491,000. The firm has a fifty day moving average of $0.03 and a two-hundred day moving average of $0.09. Q BioMed has a 1 year low of $0.01 and a 1 year high of $0.66.

Q BioMed (OTCMKTS:QBIO – Get Rating) last posted its quarterly earnings data on Thursday, July 28th. The company reported ($0.06) EPS for the quarter. The company had revenue of $0.17 million for the quarter.

About Q BioMed

Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.

Featured Stories

• Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
• Domino's Pizza Rises To The Occasion In Q3
• Constellation Brands Stock May Offer Safety in the Market Storm
• Amgen Shares Leap Higher On Upbeat Outlook For Obesity Treatment
• O'Reilly & AutoZone Outperform The S&P: Is Either A Better Stock?
• Three Dividend Growers the Institutions Are Buying

Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.